Core Viewpoint - A class action lawsuit has been filed against UnitedHealth Group Incorporated for allegedly making false and misleading statements regarding its corporate strategy and practices, which led to investor losses during the specified class period [1][3]. Summary by Relevant Sections Lawsuit Details - The lawsuit was filed in the United States District Court for the Southern District of New York on behalf of individuals and entities that purchased UnitedHealth securities between December 3, 2024, and April 16, 2025 [1]. - Investors have until July 7, 2025, to apply to be appointed as lead plaintiff in the lawsuit [1]. Allegations Against UnitedHealth - The lawsuit claims that UnitedHealth engaged in a corporate strategy of denying health coverage to increase profits and share price [3]. - This strategy allegedly led to regulatory scrutiny and public backlash, culminating in the murder of an individual named Brian Thompson [3]. - Following Thompson's murder, there was significant public animosity towards UnitedHealth, with some individuals celebrating the event and demanding changes in the company's practices [3]. - Despite the backlash, UnitedHealth reportedly maintained unrealistic guidance that did not reflect its changing corporate strategies [3]. - The lawsuit asserts that the public statements made by the defendants were materially false and misleading throughout the relevant period, resulting in investor damages when the truth was revealed [3].